Logo image of CCL-B.CA

CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis

Canada - TSX:CCL-B - CA1249003098 - Common Stock

80 CAD
-0.04 (-0.05%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CCL-B. CCL-B was compared to 7 industry peers in the Containers & Packaging industry. CCL-B has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, CCL-B is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CCL-B was profitable.
CCL-B had a positive operating cash flow in the past year.
Each year in the past 5 years CCL-B has been profitable.
In the past 5 years CCL-B always reported a positive cash flow from operatings.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CCL-B has a better Return On Assets (7.80%) than 85.71% of its industry peers.
CCL-B has a Return On Equity of 14.72%. This is amongst the best in the industry. CCL-B outperforms 100.00% of its industry peers.
The Return On Invested Capital of CCL-B (9.70%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCL-B is in line with the industry average of 7.83%.
The last Return On Invested Capital (9.70%) for CCL-B is above the 3 year average (9.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.8%
ROE 14.72%
ROIC 9.7%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CCL-B (10.58%) is better than 85.71% of its industry peers.
In the last couple of years the Profit Margin of CCL-B has grown nicely.
With an excellent Operating Margin value of 14.92%, CCL-B belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of CCL-B has remained more or less at the same level.
Looking at the Gross Margin, with a value of 29.82%, CCL-B is in line with its industry, outperforming 57.14% of the companies in the same industry.
CCL-B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.92%
PM (TTM) 10.58%
GM 29.82%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCL-B is still creating some value.
Compared to 1 year ago, CCL-B has less shares outstanding
CCL-B has less shares outstanding than it did 5 years ago.
CCL-B has a better debt/assets ratio than last year.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CCL-B has an Altman-Z score of 3.71. This indicates that CCL-B is financially healthy and has little risk of bankruptcy at the moment.
CCL-B has a Altman-Z score of 3.71. This is in the better half of the industry: CCL-B outperforms 71.43% of its industry peers.
CCL-B has a debt to FCF ratio of 3.44. This is a good value and a sign of high solvency as CCL-B would need 3.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.44, CCL-B is in line with its industry, outperforming 42.86% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that CCL-B is not too dependend on debt financing.
CCL-B has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: CCL-B outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.44
Altman-Z 3.71
ROIC/WACC1.35
WACC7.21%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 2.24 indicates that CCL-B has no problem at all paying its short term obligations.
CCL-B has a Current ratio (2.24) which is comparable to the rest of the industry.
A Quick Ratio of 1.67 indicates that CCL-B should not have too much problems paying its short term obligations.
CCL-B has a Quick ratio of 1.67. This is comparable to the rest of the industry: CCL-B outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 1.67
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

CCL-B shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.72%.
The Earnings Per Share has been growing by 10.99% on average over the past years. This is quite good.
CCL-B shows a small growth in Revenue. In the last year, the Revenue has grown by 7.90%.
Measured over the past years, CCL-B shows a small growth in Revenue. The Revenue has been growing by 6.37% on average per year.
EPS 1Y (TTM)3.72%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%-21.94%
Revenue 1Y (TTM)7.9%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%4.82%

3.2 Future

CCL-B is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.12% yearly.
CCL-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.31% yearly.
EPS Next Y1.18%
EPS Next 2Y2.61%
EPS Next 3Y5.12%
EPS Next 5YN/A
Revenue Next Year5.82%
Revenue Next 2Y4.61%
Revenue Next 3Y5.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.94, the valuation of CCL-B can be described as rather expensive.
CCL-B's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.27. CCL-B is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.17, CCL-B is valued correctly.
Based on the Price/Forward Earnings ratio, CCL-B is valued a bit more expensive than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, CCL-B is valued a bit cheaper.
Industry RankSector Rank
PE 17.94
Fwd PE 16.17
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCL-B is valued a bit more expensive than 71.43% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CCL-B.
Industry RankSector Rank
P/FCF 18.47
EV/EBITDA 9.96
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)15.15
PEG (5Y)1.63
EPS Next 2Y2.61%
EPS Next 3Y5.12%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.58%, CCL-B has a reasonable but not impressive dividend return.
CCL-B's Dividend Yield is comparable with the industry average which is at 2.97.
Compared to the average S&P500 Dividend Yield of 2.38, CCL-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.58%

5.2 History

On average, the dividend of CCL-B grows each year by 11.36%, which is quite nice.
CCL-B has paid a dividend for at least 10 years, which is a reliable track record.
CCL-B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

27.13% of the earnings are spent on dividend by CCL-B. This is a low number and sustainable payout ratio.
CCL-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.13%
EPS Next 2Y2.61%
EPS Next 3Y5.12%
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

CCL INDUSTRIES INC - CL B

TSX:CCL-B (9/15/2025, 7:00:00 PM)

80

-0.04 (-0.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11
Inst Owners39.72%
Inst Owner ChangeN/A
Ins Owners1.91%
Ins Owner ChangeN/A
Market Cap13.95B
Analysts83.16
Price Target94.55 (18.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.58%
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP27.13%
Div Incr Years23
Div Non Decr Years34
Ex-Date09-15 2025-09-15 (0.32)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.18%
Min EPS beat(2)2.15%
Max EPS beat(2)4.21%
EPS beat(4)2
Avg EPS beat(4)-0.12%
Min EPS beat(4)-5.47%
Max EPS beat(4)4.21%
EPS beat(8)4
Avg EPS beat(8)3.16%
EPS beat(12)5
Avg EPS beat(12)1.6%
EPS beat(16)8
Avg EPS beat(16)1.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.75%
Max Revenue beat(2)-0.94%
Revenue beat(4)0
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)-0.08%
Revenue beat(8)1
Avg Revenue beat(8)-1.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.97%
Revenue beat(16)5
Avg Revenue beat(16)-1.23%
PT rev (1m)1.09%
PT rev (3m)1.53%
EPS NQ rev (1m)-0.15%
EPS NQ rev (3m)-0.84%
EPS NY rev (1m)2.02%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 17.94
Fwd PE 16.17
P/S 1.86
P/FCF 18.47
P/OCF 12.41
P/B 2.59
P/tB 8
EV/EBITDA 9.96
EPS(TTM)4.46
EY5.58%
EPS(NY)4.95
Fwd EY6.19%
FCF(TTM)4.33
FCFY5.41%
OCF(TTM)6.45
OCFY8.06%
SpS42.91
BVpS30.84
TBVpS9.99
PEG (NY)15.15
PEG (5Y)1.63
Profitability
Industry RankSector Rank
ROA 7.8%
ROE 14.72%
ROCE 12.89%
ROIC 9.7%
ROICexc 10.91%
ROICexgc 20.67%
OM 14.92%
PM (TTM) 10.58%
GM 29.82%
FCFM 10.09%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.44
Debt/EBITDA 1.63
Cap/Depr 82.22%
Cap/Sales 4.93%
Interest Coverage 19.62
Cash Conversion 71.84%
Profit Quality 95.38%
Current Ratio 2.24
Quick Ratio 1.67
Altman-Z 3.71
F-Score8
WACC7.21%
ROIC/WACC1.35
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)3.72%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%-21.94%
EPS Next Y1.18%
EPS Next 2Y2.61%
EPS Next 3Y5.12%
EPS Next 5YN/A
Revenue 1Y (TTM)7.9%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%4.82%
Revenue Next Year5.82%
Revenue Next 2Y4.61%
Revenue Next 3Y5.31%
Revenue Next 5YN/A
EBIT growth 1Y10.18%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year41.68%
EBIT Next 3Y15.95%
EBIT Next 5YN/A
FCF growth 1Y54.07%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y11.94%
OCF growth 3Y8.25%
OCF growth 5Y6.42%